Leiomyosarcoma other imaging findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(5 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Leiomyosarcoma}}
{{Leiomyosarcoma}}
{{CMG}}
{{CMG}}{{AE}} {{Nnasiri}}


==Overview==
==Overview==
PET and PET/CT and Bone scan may prove particularly useful in evaluating patients who have undergone surgery in looking for local disease recurrence, or in the search for metastatic lesions.
PET scan can be very useful to detect tumor size, grade and location. Primary tumor size, tumor histologic grade, and tumor anatomic locations have been shown to correlate with patient outcome in general sarcoma tumor populations.


==PET==
==PET==
*'''Positron emission tomography (PET) scan:''' When doing this test, a small amount of a radioactive medium is injected into your body and absorbed by the organs or tissues. This radioactive substance gives off energy which in turn is used to produce the images. PET can provide more helpful information than either CT or MRI scans. It is useful to see if the sarcoma has spread to the lymph nodes and it is also useful for your doctor to locate where the sarcoma has spread.  
*'''Positron emission tomography (PET) scan''' is used in clinical practice in order to detect tumor location, histological grade and size, there is a correlation between patient outcome in sarcomas and these criteria. Larger tumors have shown to uptake more radioisotope on PET scan. A more accurate description of tumor is provided and guide physicians in their treatment options. <ref name="PuntEary2009">{{cite journal|last1=Punt|first1=Stephanie E.W.|last2=Eary|first2=Janet F.|last3=OʼSullivan|first3=Janet|last4=Conrad|first4=Ernest U.|title=Fluorodeoxyglucose positron emission tomography in leiomyosarcoma: imaging characteristics|journal=Nuclear Medicine Communications|volume=30|issue=7|year=2009|pages=546–549|issn=0143-3636|doi=10.1097/MNM.0b013e32832bcaec}}</ref>


==Bone Scan==
==Bone Scan==
*'''Whole Bone Scan:''' The goal of a whole body bone scan is to show if a sarcoma has metastasized to your bones.
*'''Whole body bone scan or PET-CT scan''' are widely available and most sensitive and specific methods to detect metastasis to bones. <ref name="HeindelGübitz2014">{{cite journal|last1=Heindel|first1=Walter|last2=Gübitz|first2=Raphael|last3=Vieth|first3=Volker|last4=Weckesser|first4=Matthias|last5=Schober|first5=Otmar|last6=Schäfers|first6=Michael|title=The Diagnostic Imaging of Bone Metastases|journal=Deutsches Aerzteblatt Online|year=2014|issn=1866-0452|doi=10.3238/arztebl.2014.0741}}</ref>


==References==
==References==

Latest revision as of 19:28, 6 March 2019

Leiomyosarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Leiomyosarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Leiomyosarcoma other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Leiomyosarcoma other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Leiomyosarcoma other imaging findings

CDC on Leiomyosarcoma other imaging findings

Leiomyosarcoma other imaging findings in the news

Blogs on Leiomyosarcoma other imaging findings

Directions to Hospitals Treating Leiomyosarcoma

Risk calculators and risk factors for Leiomyosarcoma other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]

Overview

PET scan can be very useful to detect tumor size, grade and location. Primary tumor size, tumor histologic grade, and tumor anatomic locations have been shown to correlate with patient outcome in general sarcoma tumor populations.

PET

  • Positron emission tomography (PET) scan is used in clinical practice in order to detect tumor location, histological grade and size, there is a correlation between patient outcome in sarcomas and these criteria. Larger tumors have shown to uptake more radioisotope on PET scan. A more accurate description of tumor is provided and guide physicians in their treatment options. [1]

Bone Scan

  • Whole body bone scan or PET-CT scan are widely available and most sensitive and specific methods to detect metastasis to bones. [2]

References

  1. Punt, Stephanie E.W.; Eary, Janet F.; OʼSullivan, Janet; Conrad, Ernest U. (2009). "Fluorodeoxyglucose positron emission tomography in leiomyosarcoma: imaging characteristics". Nuclear Medicine Communications. 30 (7): 546–549. doi:10.1097/MNM.0b013e32832bcaec. ISSN 0143-3636.
  2. Heindel, Walter; Gübitz, Raphael; Vieth, Volker; Weckesser, Matthias; Schober, Otmar; Schäfers, Michael (2014). "The Diagnostic Imaging of Bone Metastases". Deutsches Aerzteblatt Online. doi:10.3238/arztebl.2014.0741. ISSN 1866-0452.


Template:WikiDoc Sources